Subscribe to Newsletter
Subspecialties Glaucoma

Early Days

How useful would it be to have a test capable of picking up signs of glaucoma even 18 months earlier than with current methods, such as OCT? A new way of visualizing retinal cells, called DARC (Detection-of-Apoptosing-Retinal-Cells), developed as part of a clinical trial sponsored by the UCL Institute of Ophthalmology in London, UK, uses a fluorescent dye to illuminate cells in the process of apoptosis.

Then, an AI-aided algorithm analyzes patients’ retinal scans and refers those with higher DARC counts for further diagnosis. The trial found a significantly raised DARC number in patients who later progressed. The new method could also be used to test patients with AMD, as well as other neurodegenerative diseases.

Figure 1. A patient’s retina showing hyperfluorescent signals; each white spot is a single affected retinal nerve cell. Imagery supported by DARC technology, UCL/Western Eye Hospital.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. EM Normando et al., Expert Rev Mol Diagn, [Epub ahead of print] (2020). PMID: 32310684.
About the Author
Aleksandra Jones

Editor of The Ophthalmologist

Having edited several technical publications over the last decade, I crossed paths with quite a few of Texere's current team members, and I only ever heard them sing the company's praises. When an opportunity arose to join Texere, I jumped at the chance! With a background in literature, I love the company's ethos of producing genuinely engaging content, and the fact that it is so well received by our readers makes it even more rewarding.

Related Case Studies
Business & Profession Glaucoma
TrabEx Pro: The Next Level in MIGS

| Contributed by MST

Finding Ocular Surface Inflammation

| Contributed by Quidel

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: